Literature DB >> 19377212

Interleukin-6 and C-reactive protein in pathogenesis of diabetic nephropathy: new evidence linking inflammation, glycemic control, and microalbuminuria.

Nikhil Choudhary1, Ravinder S Ahlawat.   

Abstract

INTRODUCTION: Recent studies have shown that subclinical inflammation is a part of type 2 diabetes mellitus. This study was designed to explore the relationships between low-grade inflammation and renal microangiopathy in patients with type 2 diabetes mellitus.
MATERIALS AND METHODS: Sixty patients with type 2 diabetes mellitus were included in the study and further divided into normoalbuminurics, microalbuminurics, and macroalbuminurics, of 20 patients each. We analyzed serum concentrations of high-sensitivity C-reactive protein (HS-CRP) and interleukin-6 (IL-6) and studied their correlation with proteinuria. The patients and a control group of 20 healthy individuals were followed-up for a period of 6 months and the markers measured again.
RESULTS: A positive correlation was found between urinary albumin excretion and levels of HS-CRP (r = 0.781, P < .001) and IL-6 (r = 0.708, P < .001). The level of glcosylated hemoglobin (HbA1c) showed a significant positive correlation with urinary albumin excretion (r = 0.630, P < .001), CRP (r = 0.750, P < .001), and IL-6 (r = 0.680, P < .001). Levels of HbA1c, HS-CRP, and IL-6 significantly decreased in all three diabetic groups after 6 months of treatment. Also, the percentage of HbA1c decrement correlated well with the decrease percentage in HS-CRP (r = .277, P = .01).
CONCLUSIONS: Inflammatory markers in early type 2 diabetic nephropathy are elevated and are independently associated with urinary albumin excretion. It is possible to hypothesize on the participation of locally released cytokines in the development of kidney damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19377212

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  18 in total

Review 1.  B cells in type 1 diabetes mellitus and diabetic kidney disease.

Authors:  Mia J Smith; Kimber M Simmons; John C Cambier
Journal:  Nat Rev Nephrol       Date:  2017-10-17       Impact factor: 28.314

Review 2.  Role of the Immune System in Diabetic Kidney Disease.

Authors:  Fionnuala B Hickey; Finian Martin
Journal:  Curr Diab Rep       Date:  2018-03-12       Impact factor: 4.810

3.  Simvastatin ameliorates low-dose streptozotocin-induced type 2 diabetic nephropathy in an experimental rat model.

Authors:  Siwei Zhang; Huali Xu; Xiaofeng Yu; Yuchen Wang; Fanfan Sun; Dayuan Sui
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Decrease in neuroimmune activation by HSV-mediated gene transfer of TNFα soluble receptor alleviates pain in rats with diabetic neuropathy.

Authors:  Kathryn L Maier Ortmann; Munmun Chattopadhyay
Journal:  Brain Behav Immun       Date:  2014-05-29       Impact factor: 7.217

5.  Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes.

Authors:  Siwei Zhang; Huali Xu; Xiaofeng Yu; Yi Wu; Dayun Sui
Journal:  Exp Ther Med       Date:  2017-05-18       Impact factor: 2.447

6.  Monocyte lymphocyte ratio As a predictor of Diabetic Kidney Injury in type 2 Diabetes mellitus; The MADKID Study.

Authors:  Mehmet Zahid Kocak; Gulali Aktas; Tuba Taslamacioglu Duman; Burcin Meryem Atak; Ozge Kurtkulagi; Hikmet Tekce; Satilmis Bilgin; Betül Alaca
Journal:  J Diabetes Metab Disord       Date:  2020-07-29

7.  Soy milk consumption, inflammation, coagulation, and oxidative stress among type 2 diabetic patients with nephropathy.

Authors:  Maryam Sadat Miraghajani; Ahmad Esmaillzadeh; Mojgan Mortazavi Najafabadi; Maryam Mirlohi; Leila Azadbakht
Journal:  Diabetes Care       Date:  2012-07-11       Impact factor: 19.112

8.  Growth hormone exacerbates diabetic renal damage in male but not female rats.

Authors:  Jennifer L Whitney; Christine Maric Bilkan; Kathryn Sandberg; Adam K Myers; Susan E Mulroney
Journal:  Biol Sex Differ       Date:  2013-06-27       Impact factor: 5.027

9.  TNF-α and microalbuminuria in patients with type 2 diabetes mellitus.

Authors:  I-Th Lampropoulou; M Stangou; A Papagianni; T Didangelos; F Iliadis; G Efstratiadis
Journal:  J Diabetes Res       Date:  2014-12-22       Impact factor: 4.011

10.  Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in db/db Mice Using Cytokine Antibody Array.

Authors:  Xue Mei Fan; Chun Lian Huang; Yi Ming Wang; Ning Li; Qiong Lin Liang; Guo An Luo
Journal:  J Diabetes Res       Date:  2018-02-22       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.